Ocrelizumab safety update: Encouraging rates of serious infection, malignancyMay 18, 2018Multiple Sclerosis
VIDEO: AAN MS guidelines aim to help clinicians weigh expanding drug choicesApril 24, 2018Multiple Sclerosis
Blood-brain barrier health may signal early loss of MS treatment responseApril 20, 2018Multiple Sclerosis
Frankincense extract may reduce disease activity in relapsing-remitting MSMarch 27, 2018Multiple Sclerosis
Siponimod trial ‘first’ to show delayed disability in secondary progressive MSMarch 22, 2018Multiple Sclerosis
MRI finds PML in some natalizumab-treated patients despite negative CSF, no symptomsMarch 20, 2018Multiple Sclerosis
